awmsg logo



green tea leaf extract (Catephen®)


Reference No. 2739

Publication date:
05/10/2016


Appraisal information

green tea leaf extract (Catephen®) 10 % ointment


Company: Kora Corporation Ltd trading as Kora Healthcare
BNF category: Skin
NMG meeting date: 20/07/2016
AWMSG meeting date: 21/09/2016
   
   
Submission Type: Full Submission
Status: Recommended with restrictions
Advice No: 2416
Ministerial ratification: 04/10/2016

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Green tea leaf extract (Catephen®) is recommended as an option for restricted use within NHS Wales. Green tea leaf extract (Catephen®) is licensed for the cutaneous treatment of external genital and perianal warts (condylomata acuminata) in immunocompetent patients from the age of 18 years. Green tea leaf extract (Catephen®) is restricted for use in patients not suitable for podophyllotoxin or who have not responded to treatment with podophyllotoxin. Green tea leaf extract (Catephen®) is not recommended for use within NHS Wales outside of this subpopulation.
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download
Final Appraisal Recommendation (FAR)
Download